Vanderbilt is one of 16 North American sites conducting the Tolerance Using Plasmid in People with Type 1 Diabetes (TOPPLE) study, a phase 1 investigation that tests the safety and dosing of a new plasmid therapy.

Vanderbilt has created a pediatric emergency department to primary care clinic transfer protocol as an alternative for using the ED for non-urgent conditions that can be treated in a primary care setting.

Gastrointestinal inflammation, such as occurs in inflammatory bowel disease, triggers the expansion of a population of “bone-eating” cells, leading to bone loss.

Vanderbilt researchers have found another reason to vaccinate children against COVID-19: to help reduce the likelihood of neurologic complications caused by the virus.

Vanderbilt researchers have received a grant to study whether drugs given to premature infants in the neonatal intensive care unit (NICU) contribute to a potentially lethal condition called patent ductus arteriosus.

A pediatric infectious diseases expert answers questions parents might have about the risk of mpox risk to children.

Doctors at Vanderbilt are seeing an unusually high number of young patients infected with a virus called parechovirus.